Evidence map›Paper›PMID 35586707›Full record

ArticleLeukemia research reports2022

Adelaide Kwon, Ibrahim Ibrahim, Tri Le, Jesse Manuel Jaso, Olga Weinberg, Franklin Fuda, Weina Chen

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia research reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. The impact of SETBP1 mutations in neurological diseases and cancer.Genes to cells : devoted to molecular & cellular mechanisms · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Adelaide KwonMedical School, University of Texas Southwestern Medical Center at Dallas, TX, USA.
Ibrahim IbrahimDepartments of Internal Medicine/Division of Hematology and Oncology, University of Texas Southwestern Medical Center at Dallas, TX, USA.
Tri LeDepartments of Internal Medicine/Division of Hematology and Oncology, University of Texas Southwestern Medical Center at Dallas, TX, USA.
Jesse Manuel JasoDepartment of Pathology, University of Texas Southwestern Medical Center at Dallas, 2330 Inwood Rd, TX, 75390-9317 USA.
Olga WeinbergDepartment of Pathology, University of Texas Southwestern Medical Center at Dallas, 2330 Inwood Rd, TX, 75390-9317 USA.
Franklin FudaDepartment of Pathology, University of Texas Southwestern Medical Center at Dallas, 2330 Inwood Rd, TX, 75390-9317 USA.
Weina ChenDepartment of Pathology, University of Texas Southwestern Medical Center at Dallas, 2330 Inwood Rd, TX, 75390-9317 USA.
The University of Texas Southwestern Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic myelomonocytic leukemia (CMML) is a clonal myeloid neoplasm characterized by sustained monocytosis and mutations in

Indexed as

Atypical chronic myeloid leukemiaChronic myelomonocytic leukemiaChronic neutrophilic leukemiaCSF3R

Identifiers

PMID35586707
PMCPMC9108757
OpenAlexW4229048233

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.